Elder Granger, Director at Better Therapeutics, Inc. (BTTX), bought 600 shares at $0.87 ($522) on 2023-05-16, disclosed to the SEC on 2023-05-18.
Open-market purchase of $522 BTTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CI | SELL | 2024-06-13 | $338K | — | Filing → |
| BTTX | BUY | 2023-07-31 | $25K | — | Filing → |
| CI | SELL | 2023-03-14 | $175K | — | Filing → |